Department of Twin Research, King's College London, St Thomas' Hospital Campus, London, UK.
School of Medicine, Nottingham City Hospital, Nottingham, UK.
Gut Microbes. 2021 Jan-Dec;13(1):1-24. doi: 10.1080/19490976.2021.1897212.
The gut microbiota plays an important role in cardio-metabolic diseases with diet being among the strongest modulators of gut microbiota composition and function. Resistant dietary carbohydrates are fermented to short-chain fatty acids (SCFAs) by the gut bacteria. Fiber and omega-3 rich diets increase SCFAs production and abundance of SCFA-producing bacteria. Likewise, SCFAs can improve gut barrier integrity, glucose, and lipid metabolism, regulate the immune system, the inflammatory response, and blood pressure. Therefore, targeting the gut microbiota with dietary strategies leading to increased SCFA production may benefit cardio-metabolic health. In this review, we provide an overview of the association between diet, SCFAs produced by the gut microbiota and cardio-metabolic diseases. We first discuss the association between the human gut microbiota and cardio-metabolic diseases, then investigate the role of SCFAs and finally explore the beneficial effects of specific dietary interventions that can improve cardio-metabolic outcomes through boosting the SCFA production.
肠道微生物群在心血管代谢疾病中发挥着重要作用,饮食是调节肠道微生物群组成和功能的最强因素之一。膳食纤维中的碳水化合物可被肠道细菌发酵为短链脂肪酸(SCFAs)。富含纤维和欧米伽 3 的饮食可增加 SCFA 的产生和产生 SCFA 的细菌的丰度。同样,SCFAs 可以改善肠道屏障完整性、葡萄糖和脂质代谢、调节免疫系统、炎症反应和血压。因此,通过增加 SCFA 产生的饮食策略靶向肠道微生物群可能有益于心血管代谢健康。在这篇综述中,我们提供了饮食、肠道微生物群产生的 SCFAs 与心血管代谢疾病之间关联的概述。我们首先讨论了人类肠道微生物群与心血管代谢疾病之间的关联,然后研究了 SCFAs 的作用,最后探讨了通过增加 SCFA 产生来改善心血管代谢结果的特定饮食干预的有益效果。